Get 20M+ Full-Text Papers For Less Than $1.50/day. Subscribe now for You or Your Team.

Learn More →

Vismodegib in patients with advanced basal cell carcinoma (STEVIE): a pre-planned interim analysis of an international, open-label trial.

Vismodegib in patients with advanced basal cell carcinoma (STEVIE): a pre-planned interim... http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png The Lancet Oncology Pubmed

Vismodegib in patients with advanced basal cell carcinoma (STEVIE): a pre-planned interim analysis of an international, open-label trial.

Vismodegib in patients with advanced basal cell carcinoma (STEVIE): a pre-planned interim analysis of an international, open-label trial.

The Lancet Oncology , Volume 16 (6): 8 – Aug 31, 2015

Loading next page...
 
/lp/pubmed/vismodegib-in-patients-with-advanced-basal-cell-carcinoma-stevie-a-pre-qatYuyOWIj

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

ISSN
1470-2045
DOI
10.1016/S1470-2045(15)70198-1
pmid
25981813

Abstract

Journal

The Lancet OncologyPubmed

Published: Aug 31, 2015

There are no references for this article.